The Hallucinogen persisting perception disorder(HPPD) is the repetition of flashbacks, and sometimes these flashbacks can represent an actual psychosocial problem. These flashbacks are caused by hallucinogens(a type of drug), which are known to alter your perception on your thoughts and feelings. Some hallucinogens can be in vegetation these include: Ayahuasca, DMT, LSD, Peyote(mescaline), Psilocybin. Hallucinogens can also cause you to feel separated from your body and environment, vegetation that can cause this effect includes: DXM, Ketamine, PCP, and Salvia.
- Hallucinogen is usually caused by drugs.
- The symptoms would of course be if you seem to have multiple flashbacks or feel separated from your body and environment.
- higher heart rate
- intense emotions/feelings
- a change in your perception of time
Unfortunately there is no one medicine or therapy that will definetly help treat HPPD, but scientist have concluded that the hallucinogen disorder can be caused by different amounts of serotonin in the brain . Serotonin controls your mood, sensory recognition, sleep, hunger, body temperature, and many other things.
Benzodiazepines and antipsychotics are recommended to treat this disorder and clonazepam has worked before. PLEASE SEEK PROFESSIONAL HELP FOR MEDICATION.
Behavioral therapy is recommended for HPPD.
- these repetitious flashbacks can last for five or more years.
1) "Hallucinogen Persisting Perception Disorder after Psilocybin Consumption: A Case Study." European Psychiatry : The Journal of the Association of European Psychiatrists. U.S. National Library of Medicine, 2005. Web. 04 Jan. 2017. <https://www.ncbi.nlm.nih.gov/pubmed/15963699>.
2) "LSD-induced Hallucinogen Persisting Perception Disorder Treated with Clonazepam: Two Case Reports." The Israel Journal of Psychiatry and Related Sciences. U.S. National Library of Medicine, 2001. Web. 04 Jan. 2017. <https://www.ncbi.nlm.nih.gov/pubmed/11475916>.
3) "Hallucinogen Persisting Perception Disorder and the Serotonergic System: A Comprehensive Review including New MDMA-related Clinical Cases." European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology. U.S. National Library of Medicine, 2014. Web. 04 Jan. 2017. <https://www.ncbi.nlm.nih.gov/pubmed/24933532>.
4) National Institute on Drug Abuse, Https://www.facebook.com/NIDANIH. "Hallucinogens." DrugFacts: Hallucinogens | National Institute on Drug Abuse (NIDA). National Institutes of Health, Jan. 2016. Web. 15 Jan. 2017. <https://www.drugabuse.gov/publications/drugfacts/hallucinogens>.